Man Who Predicted March 2020 Crash Says 2021 Is The Time
If you've got money invested in the stock market, but are confused as to what to do next...This is the can't-miss interview of 2021...
Learn more here!

ATNX Insider Trading (Athenex)

Insider Ownership Percentage: 16.30%
Insider Buying (Last 12 Months): $22,553,651.23
Insider Selling (Last 12 Months): $1,898,088.12

Athenex Insider Trading History Chart

Athenex Share Price & Price History

$4.10
▼ -0.19 (-4.43%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Gain the Knowledge You Need to Successfully Trade Futures Markets
Our Technical Analysis Guide will give you the insight into today’s fast-moving markets. It’s designed to give you a head start in learning the basics of various TA tools and techniques.
Download Your Complimentary Technical Analysis Guide TODAY!
pixel

Athenex Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/5/2021Kim CampbellDirectorBuy8,250$4.42$36,465.008,250  
3/4/2021William Wei ZuoInsiderSell419,931$4.52$1,898,088.12142,883  
12/1/2020Johnson Yiu Nam LauCEOBuy1,000$13.31$13,310.003,152,959  
11/10/2020Johnson Yiu Nam LauCEOBuy1,000$11.95$11,950.00
11/6/2020Johnson Yiu Nam LauCEOBuy5,000$11.70$58,500.003,150,959  
9/24/2020Johnson Yiu Nam LauCEOBuy1,000$11.95$11,950.003,145,959  
9/21/2020Johnson Yiu Nam LauCEOBuy1,000$12.42$12,420.003,144,959  
9/14/2020Johnson Yiu Nam LauCEOBuy1,000$11.95$11,950.003,143,959  
9/14/2020Perceptive Advisors LlcMajor ShareholderBuy1,800,000$11.00$19,800,000.00  
9/12/2020Manson FokDirectorBuy16,491$11.03$181,895.731,999,609  
9/10/2020Johnson Yiu Nam LauCEOBuy10,000$11.22$112,200.003,139,959  
9/10/2020Jordan KanferDirectorBuy450$11.49$5,170.504,634  
9/10/2020Perceptive Advisors LlcMajor ShareholderBuy200,000$11.24$2,248,000.00  
9/10/2020Randoll SzeCFOBuy1,000$11.40$11,400.006,000  
6/22/2020Johnson Yiu Nam LauCEOBuy2,000$12.81$25,620.003,114,959  
6/22/2020Rudolf KwanEVPBuy1,000$12.82$12,820.00  
3/27/2020Johnson Yiu Nam LauCEOBuy1,000$7.88$7,880.003,112,959  
3/25/2020Manson FokDirectorBuy50,000$7.25$362,500.001,969,609  
3/23/2020Johnson Yiu Nam LauCEOBuy1,000$6.64$6,640.003,111,959  
3/20/2020Johnson Yiu Nam LauCEOBuy1,000$6.57$6,570.00
3/18/2020Johnson Yiu Nam LauCEOBuy2,000$5.78$11,560.003,107,959  
3/18/2020Rudolf KwanEVPBuy4,000$6.99$27,960.00
3/16/2020Johnson Yiu Nam LauCEOBuy2,000$6.99$13,980.003,105,959  
3/13/2020Benson Kwan Hung TsangDirectorBuy5,000$8.39$41,950.0010,000  
3/12/2020Rudolf KwanEVPBuy2,000$8.19$16,380.003,101,959  
3/11/2020Manson FokDirectorBuy50,000$9.66$483,000.005,000  
3/9/2020Rudolf KwanEVPBuy2,000$9.79$19,580.00  
12/23/2019Life Sciences Maste PerceptiveMajor ShareholderBuy606,302$14.54$8,815,631.08
12/17/2019Randoll SzeCFOBuy1,000$13.25$13,250.004,000  
11/7/2019Manson FokDirectorBuy50,000$11.67$583,500.001,869,609  
10/17/2019Randoll SzeCFOBuy1,000$10.99$10,990.003,000  
10/16/2019Johnson Yiu Nam LauCEOBuy6,000$10.16$60,960.003,055,959  
10/16/2019Perceptive Advisors LlcMajor ShareholderBuy67,222$10.29$691,714.38  
9/30/2019Randoll SzeCFOBuy1,000$12.62$12,620.002,000  
9/27/2019Johnson Yiu Nam LauCEOBuy3,000$12.85$38,550.003,049,959  
9/23/2019Johnson Yiu Nam LauCEOBuy5,000$13.86$69,300.003,046,959  
9/16/2019Johnson Yiu Nam LauCEOBuy5,000$13.57$67,850.003,041,959  
9/16/2019Perceptive Advisors LlcMajor ShareholderBuy30,000$13.58$407,400.00  
9/12/2019Perceptive Advisors LlcMajor ShareholderBuy13,584$14.05$190,855.20  
8/23/2019Johnson Yiu Nam LauCEOBuy5,000$14.98$74,900.003,036,959  
8/15/2019Johnson Yiu Nam LauCEOBuy10,000$14.90$149,000.003,031,959  
8/15/2019Perceptive Advisors LlcMajor ShareholderBuy30,000$15.00$450,000.00  
8/15/2019Rudolf KwanEVPBuy1,000$14.85$14,850.00  
8/8/2019Life Sciences Maste PerceptiveMajor ShareholderBuy808,481$14.67$11,860,416.27  
6/26/2019Stephanie A DavisDirectorBuy10,000$18.00$180,000.0010,000  
6/24/2019Perceptive Advisors LlcMajor ShareholderBuy20,786$17.90$372,069.40  
6/21/2019Perceptive Advisors LlcMajor ShareholderBuy23,073$17.85$411,853.05  
6/17/2019Life Sciences Maste PerceptiveMajor ShareholderBuy130,000$17.94$2,332,200.00  
6/13/2019Life Sciences Maste PerceptiveMajor ShareholderBuy75,710$17.05$1,290,855.50  
6/6/2019Jordan KanferDirectorBuy2,500$15.01$37,525.004,184  
5/6/2019Perceptive Advisors LlcMajor ShareholderBuy100,000$12.71$1,271,000.00  
3/27/2019Johnson Yiu Nam LauCEOBuy10,000$12.40$124,000.002,986,385  
3/25/2019Johnson Yiu Nam LauCEOBuy10,000$12.45$124,500.002,976,385  
3/25/2019William Wei ZuoInsiderBuy1,000$12.47$12,470.001,118,777  
3/20/2019Johnson Yiu Nam LauCEOBuy10,500$12.00$126,000.002,965,385  
3/18/2019Johnson Yiu Nam LauCEOBuy4,000$12.52$50,080.002,936,236  
3/15/2019Johnson Yiu Nam LauCEOBuy12,000$11.77$141,240.002,932,236  
3/15/2019Sheldon Trainor-DegirolamoDirectorSell54,085$11.77$636,580.45  
3/13/2019Sheldon Trainor-DegirolamoDirectorSell45,915$11.77$540,419.554,000  
3/11/2019Johnson Yiu Nam LauCEOBuy10,000$11.78$117,800.002,917,422  
3/11/2019Song-Yi ZhangDirectorSell32,240$11.85$382,044.004,000  
11/30/2018Song-Yi ZhangDirectorSell1,000,000$13.15$13,150,000.004,000  
11/19/2018Johnson Yiu Nam LauCEOBuy10,000$11.75$117,500.00  
11/19/2018Rudolf KwanEVPBuy1,000$11.70$11,700.00  
11/14/2018Jeffrey YordonInsiderBuy9,500$10.49$99,655.00198,209  
11/14/2018Johnson Yiu Nam LauCEOBuy40,000$10.47$418,800.002,887,422  
11/14/2018Randoll SzeCFOBuy1,000$10.26$10,260.001,000  
11/14/2018Rudolf KwanEVPBuy10,000$10.49$104,900.0092,224  
10/15/2018Jinn WuDirectorBuy12,500$13.47$168,375.00311,208  
9/27/2018Johnson Yiu Nam LauCEOBuy2,000$15.66$31,320.002,847,422  
9/6/2018Jinn WuDirectorBuy2,500$16.09$40,225.00266,708  
9/6/2018Johnson Yiu Nam LauCEOBuy5,000$15.84$79,200.002,825,422  
8/29/2018Song-Yi ZhangDirectorSell51,029$16.61$847,591.694,000  
8/27/2018Song-Yi ZhangDirectorSell53,439$17.11$914,341.294,000  
8/24/2018Song-Yi ZhangDirectorSell23,137$17.17$397,262.294,000  
8/22/2018Song-Yi ZhangDirectorSell102,734$17.24$1,771,134.164,000  
8/20/2018Jinn WuDirectorBuy5,000$17.20$86,000.004,000  
8/17/2018Song-Yi ZhangDirectorSell70,133$17.18$1,204,884.944,000  
8/15/2018Song-Yi ZhangDirectorSell43,845$16.53$724,757.854,000  
6/6/2018Sheldon Trainor-DegirolamoDirectorSell12,401$16.81$208,460.81  
6/4/2018Sheldon Trainor-DegirolamoDirectorSell31,633$16.81$531,750.73  
5/29/2018Song-Yi ZhangDirectorSell70,584$16.07$1,134,284.884,000  
5/25/2018Song-Yi ZhangDirectorSell9,592$16.61$159,323.124,000  
5/23/2018Sheldon Trainor-DegirolamoDirectorSell121,688$17.01$2,069,912.88  
5/17/2018Song-Yi ZhangDirectorSell26,250$16.87$442,837.504,000  
5/15/2018Song-Yi ZhangDirectorSell29,244$16.93$495,100.924,000  
See Full Table

SEC Filings (Institutional Ownership Changes) for Athenex (NASDAQ:ATNX)

57.74% of Athenex stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Athenex Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
4/5/2021Pacer Advisors Inc.14,048$60K0.0%+229.5%0.015%
3/12/2021DekaBank Deutsche Girozentrale31,900$0.35M0.0%+78.2%0.034%
2/25/2021Hsbc Holdings PLC461,090$5.10M0.0%+14.5%0.494%
2/23/2021Principal Financial Group Inc.34,826$0.39M0.0%+120.8%0.037%
2/19/2021JPMorgan Chase & Co.184,975$2.05M0.0%-11.6%0.198%
2/18/2021Old Well Partners LLC10,800$0.12M0.1%N/A0.012%
2/16/2021Orbimed Advisors LLC3,694,061$40.86M0.4%-7.1%3.958%
2/16/2021Squarepoint Ops LLC113,593$1.26M0.0%+439.4%0.122%
2/16/2021Tudor Investment Corp Et Al38,874$0.43M0.0%+76.3%0.042%
2/16/2021Nuveen Asset Management LLC506,472$5.60M0.0%+74.1%0.543%
2/16/2021Avoro Capital Advisors LLC372,500$4.12M0.1%-88.6%0.399%
2/16/2021Virginia Retirement Systems ET AL18,100$0.20M0.0%N/A0.019%
2/16/2021Engineers Gate Manager LP13,590$0.15M0.0%N/A0.015%
2/16/2021Charles Schwab Investment Management Inc.477,250$5.28M0.0%+17.3%0.511%
2/13/2021Hillhouse Capital Advisors LTD.431,440$4.77M0.0%-40.5%0.462%
2/13/2021American International Group Inc.41,199$0.46M0.0%+11.2%0.044%
2/12/2021Laurion Capital Management LP481,193$5.32M0.0%-0.3%0.516%
2/12/2021Amalgamated Bank11,011$0.12M0.0%N/A0.012%
2/12/2021The Manufacturers Life Insurance Company 42,942$0.48M0.0%+17.0%0.046%
2/12/2021Credit Suisse AG97,526$1.08M0.0%+23.8%0.104%
2/12/2021Jaffetilchin Investment Partners LLC174,616$1.93M0.3%-6.2%0.187%
2/12/2021Virtus ETF Advisers LLC24,004$0.27M0.1%-4.4%0.026%
2/11/2021Trexquant Investment LP29,476$0.33M0.0%-32.5%0.032%
2/11/2021Northern Trust Corp814,757$9.01M0.0%+10.9%0.873%
2/11/2021Barclays PLC75,416$0.83M0.0%-3.1%0.081%
2/11/2021Citigroup Inc.18,205$0.20M0.0%-39.6%0.020%
2/11/2021Dynamic Technology Lab Private Ltd47,326$0.52M0.1%N/A0.051%
2/10/2021Rhumbline Advisers99,311$1.10M0.0%+6.3%0.106%
2/10/2021Renaissance Technologies LLC169,600$1.88M0.0%-40.4%0.182%
2/10/2021Panagora Asset Management Inc.85,751$0.95M0.0%N/A0.092%
2/10/2021HighTower Advisors LLC362,982$4.02M0.0%-0.4%0.389%
2/10/2021Junson Asset Management Hong Kong Ltd70,500$0.78M0.4%N/A0.076%
2/9/2021Wells Fargo & Company MN278,786$3.08M0.0%+27.1%0.299%
2/9/2021Bank of New York Mellon Corp262,838$2.91M0.0%+8.5%0.282%
2/9/2021ProShare Advisors LLC30,108$0.33M0.0%+45.0%0.032%
2/8/2021Alliancebernstein L.P.77,900$0.86M0.0%-6.9%0.083%
2/8/2021Russell Investments Group Ltd.88,254$0.98M0.0%+29.7%0.095%
2/5/2021BlackRock Inc.6,120,240$67.69M0.0%+17.6%6.557%
2/5/2021Aperio Group LLC13,550$0.15M0.0%+20.1%0.015%
2/5/2021SG Americas Securities LLC14,637$0.16M0.0%+57.0%0.016%
2/4/2021Los Angeles Capital Management LLC36,979$0.41M0.0%+88.6%0.040%
2/4/2021GSA Capital Partners LLP39,710$0.44M0.1%N/A0.043%
2/4/2021State of Wisconsin Investment Board98,400$1.09M0.0%-16.7%0.105%
2/4/2021Cambiar Investors LLC97,977$1.08M0.0%-3.2%0.105%
2/2/2021First Trust Advisors LP114,952$1.27M0.0%+16.0%0.123%
2/1/2021Victory Capital Management Inc.145,302$1.61M0.0%-10.4%0.156%
1/28/2021Arizona State Retirement System15,963$0.18M0.0%+17.8%0.017%
1/28/2021Zurcher Kantonalbank Zurich Cantonalbank8,240$91K0.0%+61.3%0.009%
1/27/2021Lindbrook Capital LLC4,500$50K0.0%+125.0%0.005%
1/27/2021Ingalls & Snyder LLC244,350$2.70M0.1%N/A0.262%
1/20/2021Pacer Advisors Inc.4,263$47K0.0%+92.6%0.005%
1/20/2021Deltec Asset Management LLC754,801$8.35M1.3%+41.1%0.809%
12/30/2020Deerfield Management Company L.P. Series C1,150,000$13.92M0.3%N/A1.232%
12/11/2020Virtu Financial LLC10,659$0.13M0.0%N/A0.011%
11/17/2020Paloma Partners Management Co29,820$0.36M0.0%N/A0.032%
11/17/2020California State Teachers Retirement System93,799$1.14M0.0%-15.5%0.100%
11/17/2020Schonfeld Strategic Advisors LLC873,656$10.57M0.2%+345.2%0.936%
11/16/2020Cubist Systematic Strategies LLC150,681$1.82M0.0%+485.0%0.161%
11/16/2020Point72 Asset Management L.P.270,636$3.28M0.0%-3.6%0.290%
11/16/2020Squarepoint Ops LLC21,061$0.26M0.0%N/A0.023%
11/16/2020Perceptive Advisors LLC13,532,467$161.32M2.4%+17.3%14.498%
11/16/2020ExodusPoint Capital Management LP93,493$1.13M0.0%N/A0.100%
11/13/2020Morgan Stanley29,190$0.35M0.0%-34.0%0.031%
11/13/2020ProShare Advisors LLC20,766$0.25M0.0%-9.9%0.022%
11/13/2020Jefferies Group LLC30,000$0.36M0.0%N/A0.032%
11/13/2020Charles Schwab Investment Management Inc.406,911$4.92M0.0%+7.6%0.436%
11/13/2020UBS Asset Management Americas Inc.48,800$0.59M0.0%+2.3%0.052%
11/13/2020Virtus ETF Advisers LLC25,109$0.30M0.2%-12.0%0.027%
11/12/2020JPMorgan Chase & Co.209,130$2.54M0.0%-9.2%0.224%
11/10/2020State Street Corp2,444,248$29.58M0.0%-3.0%2.991%
11/9/2020SG Americas Securities LLC9,322$0.11M0.0%-72.9%0.011%
11/9/2020Caas Capital Management LP53,963$0.65M0.0%N/A0.066%
11/9/2020The Manufacturers Life Insurance Company36,710$0.44M0.0%-16.9%0.045%
11/9/2020Jaffetilchin Investment Partners LLC186,201$2.25M0.4%+0.8%0.228%
11/9/2020Victory Capital Management Inc.162,143$1.96M0.0%+29.6%0.198%
11/9/2020LPL Financial LLC19,646$0.24M0.0%+34.1%0.024%
11/6/2020BlackRock Inc.5,205,137$62.98M0.0%-6.9%6.369%
11/6/2020Trexquant Investment LP43,695$0.53M0.0%N/A0.053%
11/6/2020Aperio Group LLC11,284$0.14M0.0%+9.5%0.014%
11/5/2020New York State Common Retirement Fund56,023$0.68M0.0%-20.2%0.069%
11/5/2020California Public Employees Retirement System128,700$1.56M0.0%-13.6%0.157%
11/5/2020First Trust Advisors LP99,103$1.20M0.0%N/A0.121%
11/5/2020Wells Fargo & Company MN219,266$2.65M0.0%-3.1%0.268%
11/4/2020American International Group Inc.37,063$0.45M0.0%-17.7%0.045%
10/30/2020BNP Paribas Arbitrage SA14,711$0.18M0.0%+109.5%0.018%
10/29/2020DekaBank Deutsche Girozentrale17,900$0.21M0.0%N/A0.022%
10/23/2020Deltec Asset Management LLC535,071$6.47M1.2%N/A0.655%
10/21/2020Cambiar Investors LLC101,252$1.23M0.1%-1.0%0.124%
10/19/2020Pacer Advisors Inc.2,213$27K0.0%N/A0.003%
10/15/2020Vigilare Wealth Management10,000$0.12M0.1%N/A0.012%
10/7/2020Pennsylvania Capital Management Inc. ADV13,126$0.17M0.1%N/A0.016%
10/7/2020Assenagon Asset Management S.A.610,067$7.38M0.0%N/A0.746%
9/15/2020Two Sigma Advisers LP180,537$2.48M0.0%-22.3%0.221%
9/15/2020Schonfeld Strategic Advisors LLC196,234$2.70M0.1%+49.9%0.240%
9/4/2020Principal Financial Group Inc.28,714$0.40M0.0%+142.8%0.035%
8/25/2020Nuveen Asset Management LLC324,076$4.46M0.0%-5.2%0.397%
8/20/2020Charles Schwab Investment Management Inc.378,124$5.20M0.0%+8.8%0.463%
8/17/2020Engineers Gate Manager LP17,240$0.24M0.0%-72.4%0.021%
8/17/2020California State Teachers Retirement System111,000$1.53M0.0%+7.6%0.136%
8/17/2020Great West Life Assurance Co. Can2,451$33K0.0%-56.9%0.003%
Data available starting January 2016

See Full Table
Athenex logo
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of various therapies for the treatment of cancer and related conditions in North America and Asia. It operates in three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral Paclitaxel, an oral dosage form, which is in Phase III trial for metastatic breast cancer, as well as various clinical studies in advanced malignancies and gastric cancer; and Oral Irinotecan and Encequidar, a potent anticancer drug that is in a Phase I study for the treatment of metastatic colorectal cancer, glioblastoma, lung, ovarian, cervical, upper gastrointestinal, and pancreatic cancer. Its Orascovery product candidates also comprise Oral Docetaxel and Encequidar, a potent anticancer drug, which is in Phase I clinical study for breast, lung, prostate, gastric, and head and neck cancers; Oral Topotecan and Encequidar, a potent anticancer drug that is Phase I clinical trial to treat lung, ovarian, and cervical cancer; and Oral Eribulin and Encequidar, an anticancer intravenous drug to treat certain patients with breast cancer and liposarcoma. In addition, the company offers Src Kinase product candidates comprising Tirbanibulin ointments for actinic keratosis, skin cancers, and psoriasis; Tirbanibulin Oral for solid and liquid tumors; and KX2-361 for glioblastoma multiforme. Further, it is developing dual absorption enhancers to inhibit the P-gp transporter and the cytochrome P450 enzymes within the gastrointestinal tract; T Cell Receptor Engineered T Cell, a cell-based immunotherapy; and PT01 (Pegtomarginase), an arginine deprivation therapy product. The company was formerly known as Kinex Pharmaceuticals LLC and changed its name to Athenex, Inc. in August 2015. Athenex, Inc. was founded in 2003 and is headquartered in Buffalo, New York.
Read More

Today's Range

Now: $4.10
$4.07
$4.28

50 Day Range

MA: $6.29
$4.08
$12.43

52 Week Range

Now: $4.10
$3.93
$15.24

Volume

1,209,183 shs

Average Volume

2,862,059 shs

Market Capitalization

$383.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Who are the company insiders with the largest holdings of Athenex?

Athenex's top insider investors include:
  1. Johnson Yiu Nam Lau (CEO)
  2. Rudolf Kwan (EVP)
  3. Manson Fok (Director)
  4. William Wei Zuo (Insider)
  5. Benson Kwan Hung Tsang (Director)
  6. Stephanie A Davis (Director)
  7. Kim Campbell (Director)
  8. Randoll Sze (CFO)
  9. Jordan Kanfer (Director)
  10. Life Sciences Maste Perceptive (Major Shareholder)
  11. Perceptive Advisors Llc (Major Shareholder)

Who are the major institutional investors of Athenex?

Athenex's top institutional shareholders include:
  1. Pacer Advisors Inc. — 0.02%

Which major investors are buying Athenex stock?

Within the last quarter, ATNX stock was bought by institutional investors including:
  1. Pacer Advisors Inc.
Within the last year, these company insiders have bought Athenex stock:
  1. Johnson Yiu Nam Lau (CEO)
  2. Rudolf Kwan (EVP)
  3. Manson Fok (Director)
  4. William Wei Zuo (Insider)
  5. Benson Kwan Hung Tsang (Director)
  6. Stephanie A Davis (Director)
  7. Kim Campbell (Director)
  8. Randoll Sze (CFO)
  9. Jordan Kanfer (Director)
  10. Life Sciences Maste Perceptive (Major Shareholder)
100X Gains On Tap as Under-the-Radar Green-Tech Stock Soars
Searching for the next 1,000% stock winner? Look no further than key Green-Techs that are driving the EV, Solar & 5G booms. Silver is the #1 element in the Green Energy Revolution & we’ve found the top silver gem – undiscovered at 10-cents per share – that’s fueling the path to a carbon-free world.
Get the details here...
pixel